Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreGaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreA new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn MoreSeasoned Industry Veterans Join Long Island Bioscience Hub’s BioEntrepreneur-in-Residence Initiative
Learn MoreCFB Client iCell Gene Therapeutics, Stony Brook University, and the University of Louisville, have received FDA clearance for an Investigational New Drug (IND) for the treatment of relapsed and refractory T-cell leukemia and lymphoma.
Learn More“With a proven record of research, discovery, innovation and product-development in the biomedical sciences, Stony Brook’s Center for Biotechnology is poised to become an important contributor to the BARDA-DRIVe initiative”
Learn More